Glycotoxins in the diet promote diabetes and diabetic complications

被引：60
|
作者：
Vlassara H. [1 ]
Striker G. [1 ]
机构：
[1] Division of Experimental Diabetes and Aging, Department of Geriatrics, Mount Sinai School of Medicine, New York, NY 10029, One Gustave Levy Place
来源：
Current Diabetes Reports | 2007年 / 7卷 / 3期
关键词：
Diabetic Complication; Aldose Reductase; Methylglyoxal; Benfotiamine; Dietary AGEs;
D O I：
10.1007/s11892-007-0037-z
中图分类号：
学科分类号：
摘要：
Oxidant stress underlines diabetes and diabetic complications, including cardiovascular, renal, and retinal disease. Advanced glycation and products (AGEs), or glycotoxins, are a significant contributor to oxidant stress in diabetes. The diet is a major, unrecognized source of AGEs. Importantly, reduction of dietary AGEs decreases circulating inflammatory markers in both diabetic patients and prediabetic patients complications in animal models. This beneficial outcome requires only a 50% decrease in dietary AGEs, making this necessary intervention practical and inexpensive. Copyright © 2007 by Current Medicine Group LLC.
引用
收藏
页码：235 / 241
页数：6
相关论文
共 50 条
  • [41] The Frequency of Depression in Turkish Patients With Diabetes and Diabetic Complications
    Saglam, Zuhal Aydan
    Saler, Tayyibe
    Erdem, Tijen Yesim
    Ataoglu, Esra
    Temiz, Levent Umit
    Yenigun, Mustara
    ENDOCRINOLOGIST, 2010, 20 (01): : 19 - 22
  • [42] Progress in genetics of type 2 diabetes and diabetic complications
    Shojima, Nobuhiro
    Yamauchi, Toshimasa
    JOURNAL OF DIABETES INVESTIGATION, 2023, 14 (04) : 503 - 515
  • [43] The potential role of lncRNAs in diabetes and diabetic microvascular complications
    Chen, Yanxia
    He, Yinxi
    Zhou, Hong
    ENDOCRINE JOURNAL, 2020, 67 (07) : 659 - 668
  • [44] Diabetes, Diabetic Complications, and Phosphate Toxicity: A Scoping Review
    Brown, Ronald B.
    CURRENT DIABETES REVIEWS, 2020, 16 (07) : 674 - 689
  • [45] Protein O-GlcNAcylation in diabetes and diabetic complications
    Ma, Junfeng
    Hart, Gerald W.
    EXPERT REVIEW OF PROTEOMICS, 2013, 10 (04) : 365 - 380
  • [46] Olfactory dysfunction and diabetic complications in type 2 diabetes
    Cardella, A.
    Mozzanica, F.
    Ferrulli, A.
    Luzi, L.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S484 - S484
  • [47] Progression of diabetic complications in patients with type 1 diabetes
    Glazunova, A.
    Arutyunova, M.
    Shamkhalova, M.
    Shestakova, M.
    Moysyuk, Y.
    Pinchuk, A.
    Dmitriev, I.
    Arzumanov, S.
    Dedov, I.
    DIABETOLOGIA, 2017, 60 : S207 - S207
  • [48] Implementation of screening for diabetic complications - The VW diabetes project
    Joergens, V
    Gruesser, M
    Hoffstadt, K
    Hartmann, P
    DIABETES, 1999, 48 : A194 - A194
  • [49] Diabetic complications at the time of diagnosis of type 2 diabetes
    Pappas, A.
    Gikas, A.
    Markakis, E.
    Anyfantakis, A.
    Bristianou, M.
    Chryssoula, B.
    Kontouri, A.
    Kouloukoura, A.
    Kyrlaki, E.
    Dimitriadis, G.
    Lanaras, L.
    Makrilakis, K.
    Lampadiari, V.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S143 - S144
  • [50] Emerging Targets in Type 2 Diabetes and Diabetic Complications
    Demir, Sevgican
    Nawroth, Peter P.
    Herzig, Stephan
    Ustunel, Bilges Ekim
    ADVANCED SCIENCE, 2021, 8 (18)
12345